The First People's Hospital of Changzhou
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1918-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.czfph.com/en
Clinical Trials
27
Active:9
Completed:6
Trial Phases
5 Phases
Phase 1:2
Phase 2:17
Phase 3:1
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (25 trials with phase data)• Click on a phase to view related trials
Phase 2
17 (68.0%)Not Applicable
3 (12.0%)Phase 1
2 (8.0%)Phase 4
2 (8.0%)Phase 3
1 (4.0%)Clinical Trial of Safety and Efficacy of Intracranial Laser Balloon Dilation Catheter in Patients With Symptomatic Intracranial Atherosclerotic Stenosis: A Prospective, Multi-center, Randomized Comparison
Not Applicable
- Conditions
- Prospective, Multicenter, Randomized, Controlled, and Superior Efficiency
- First Posted Date
- 2025-04-30
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 128
- Registration Number
- NCT06950242
- Locations
- 🇨🇳
The First People's Hospital of Changzhou., Changzhou, Jiangsu, China
Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis
Phase 3
Recruiting
- Conditions
- Anti-N-Methyl-D-Aspartate Receptor Encephalitis
- Interventions
- Drug: Ofatumumab combined with daratumumabDrug: Repeated intravenous immunoglobulin/plasma exchange therapy
- First Posted Date
- 2025-03-10
- Last Posted Date
- 2025-07-15
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 200
- Registration Number
- NCT06867991
- Locations
- 🇨🇳
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
🇨🇳The First People's Hospital of Changzhou, Changzhou, Jiangsu, China
Wingspan Stent System for Intracranial Artery Stenosis
Completed
- Conditions
- Intracranial Artery StenosisStentEndovascular Therapy
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 43
- Registration Number
- NCT06618222
- Locations
- 🇨🇳
The First People's Hospital of Changzhou, Changzhou, Jiangsu, China
Regorafenib and Sintilimab in Combination with Electroacupuncture in MSS CRC
Not Applicable
Recruiting
- Conditions
- Colorectal Cancer Metastatic
- Interventions
- First Posted Date
- 2024-06-13
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 30
- Registration Number
- NCT06456515
- Locations
- 🇨🇳
The First People's Hospital of Changzhou, Changzhou, China
Efficacy of Henagliflozin for Weight Loss in Obesity Without Diabetes
Phase 4
Not yet recruiting
- Conditions
- ObeseWeight LossPre-diabetes
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-01-22
- Last Posted Date
- 2024-01-22
- Lead Sponsor
- The First People's Hospital of Changzhou
- Target Recruit Count
- 300
- Registration Number
- NCT06216340
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
News
No news found